STATEMENT OF RETRACTION

Author：

ISSN： 1042-8194

Source： Leukemia and Lymphoma, Vol.54, Iss.7, 2013-07, pp. : 1571-1571

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Retraction

Future Oncology, Vol. 4, Iss. 3, 2008-06 ,pp. : 448-448

Future Medicine

Access to resources Recommend Favorite

Retraction

By Hill Richard P. Rauth A. Michael

International Journal of Radiation Biology, Vol. 87, Iss. 12, 2011-12 ,pp. : 1210-1210

Informa Healthcare

Access to resources Recommend Favorite

Statement of Retraction: Huang H, Wu D, Fu J, Chen G. “Multiple myeloma cells undergo differentiation upon exposure to rosiglitazone and all-trans retinoic acid”

Leukemia and Lymphoma, Vol. 55, Iss. 6, 2014-06 ,pp. : 1437-1437

Informa Healthcare

Access to resources Recommend Favorite

Statement of Retraction: Hongying Lv, Qicai Li, Wengsheng Qiu, Jinyu Xiang, Hongjun Wei, Hua Liang, Aihua Sui and Jun Liang “Genetic Polymorphism of XRCC1 Correlated with Response to Oxaliplatin-based Chemotherapy in Advanced Colorectal Cancer”

Cancer Investigation, Vol. 31, Iss. 10, 2013-12 ,pp. : 661-661

Informa Healthcare

Access to resources Recommend Favorite

Brussels Statement document

By Piccart M. Cataliotti L. Buchanan M. Freilich G. Jassem J.

European Journal of Cancer, Vol. 37, Iss. 11, 2001-07 ,pp. : 1335-1337

Elsevier

Access to resources Recommend Favorite